The guidelines will provide authoritative information to health professionals at a time when there is currently great uncertainty amongst GPs on how to treat the condition.
ADHD in the population is considered to be about four per cent making it a common disorder. There are no licensed drugs for managing ADHD specifically in adults, leading to uncertainty amongst health professionals on how best to treat these new cases. Yet drugs licensed for related conditions have proven to be effective.
The British Association of Psychopharmacology (BAP) guidelines provide the appropriate evidence and experience to permit health professionals to use unlicensed medicines if the clinical need cannot be met by licensed medicines, as advised by the British National Formulary (BNF).
“Treatment relieves suffering for the patient and family, and also alleviates social costs in unemployment, crime, incarceration, smoking, substance use and driving accidents”, said Professor David Nutt from the BAP consensus group. “This information needs to be addressed by the NHS so that resources can be redirected to provide appropriate and evidence-based care for adults with ADHD.”
The BAP guidelines on adult ADHD are based on expert opinion derived from childhood evidence. It is the first time that guidelines for ADHD in adults, and in adolescents in transition to adult services, have been published and arrive at a time when they can influence the new specialist services that the NHS is establishing in response to this growing need.
Juliet Upton | alfa
Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan
Prospect for more effective treatment of nerve pain
20.02.2017 | Universität Zürich
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
21.02.2017 | Earth Sciences
21.02.2017 | Medical Engineering
21.02.2017 | Trade Fair News